Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: Optimization of perioperative approaches for advanced and late stages of gastric cancer: clinical proposal based on literature evidence, personal experience, and ongoing trials and research

Fig. 1

Optimized clinical management of AGC based on current evidence and personal experiences. M0/X AGC refers to AGC without macroscopic metastasis; M1 AGC refers to AGC with clinical macroscopic metastasis; P0 Cy0 refers to no macroscopic peritoneal metastasis and no positive cytology; P0 Cy1 refers to no macroscopic peritoneal metastasis but positive cytology; P1 Cy0-1 refers to macroscopic peritoneal metastasis with or without positive cytology; NAC refers to neoadjuvant combined therapy; HIPEC refers to hyperthermic intraperitoneal chemotherapy [34]; NIPS refers to neoadjuvant bidirectional intraperitoneal/systemic chemotherapy [35]; PC refers to palliative combined therapy; PR refers to partial remission, SD refers to stable disease, and PD refers to progressive disease according to RECIST evaluation criteria; AC refers to adjuvant combined therapy; AR refers to adjuvant radiotherapy

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us